Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

2 years ago

• Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites…

Rakovina Therapeutics Presents Preclinical Data Supporting Potential Broad Anticancer Activity of kt-4000 Series at the American Association of Cancer Research (AACR) Annual General Meeting

2 years ago

VANCOUVER, British Columbia, April 12, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company committed…

Icario Names Healthcare Veteran Troy Jelinek Chief Commercial Officer

2 years ago

Former UnitedHealth Group Executive to Help Lead Growth in Health Plan and Provider MarketsMINNEAPOLIS, April 12, 2022 (GLOBE NEWSWIRE) --…

XP Health Partners With Noyo to Effortlessly Connect with Benefits Administration Platforms and Insurance Carriers, Securely and at Scale

2 years ago

XP Health’s AI-powered Vision Platform to Deliver Enhanced Group Benefits with Noyo IntegrationSAN CARLOS, Calif. and SAN FRANCISCO, April 12, 2022…

Progenity to Become Biora Therapeutics as it Completes Transformation

2 years ago

Upcoming Change Reflects the Company’s Focus on Oral Delivery of BiotherapeuticsSAN DIEGO, April 12, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc.…

Cannabix Technologies to Present at International Association for Chemical Testing (IACT) Conference in Arizona

2 years ago

Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia,…

Healthy Extracts Expects Q1 2022 Net Revenue up 187% to Record $489,000, Driving First Profitable Quarter

2 years ago

LAS VEGAS, April 12, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based…

Ocugen, Inc. Provides Update on its Phase 2/3 Study of COVAXIN™ (BBV152)

2 years ago

MALVERN, Pa., April 12, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and…

CytoDyn Announces Publication of Peer-Reviewed Paper, “Suppression of Human and Simian Immunodeficiency Virus Replication with the CCR5-Specific Antibody Leronlimab in Two Species”

2 years ago

VANCOUVER, Washington, April 12, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company…

IO Biotech Announces Initiation of Phase 2 Trial of IO102-IO103 in Combination With KEYTRUDA® (pembrolizumab) as First-Line Treatment in a Multi-Arm Basket Trial

2 years ago

NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer…